Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

Keeping Current CME
26/03/2024 37 min
Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

Listen "Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations"

Descargar episodio Ver en sitio original

Episode Synopsis

Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000409?ecd=bdc_podcast_libsyn_mscpedu

More episodes of the podcast Keeping Current CME

Genetic Testing for Dravet Syndrome: A Patient–Physician Communication Module 16/01/2026
Patient-Centered Approaches to Indolent Systemic Mastocytosis: Advancing Care and Reducing Diagnostic Delays 13/01/2026
Highlights From the Annual Neuro-Oncology Conference: Redefining IDH-Mutant Glioma Management 06/01/2026
Empowering Nursing Care in Acromegaly: Strategies for Enhanced Diagnosis and Management 06/01/2026
Navigating Advances in IgA Nephropathy: Key Developments for Therapies Targeting the B-Cell Pathway 31/12/2025
Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow 29/12/2025
From Approval to Practice: Expert Approaches to Infusion Site Reactions in Parkinson Treatment 26/12/2025
Real-Time Insights Into the Diagnosis and Management of ATTR: From Genetic Insight to Therapeutic Innovation 23/12/2025
Building the Case for Nonsteroidal Topical Atopic Dermatitis Treatments 23/12/2025
Case Review in Narcolepsy and Idiopathic Hypersomnia: Integrating Treatment Decisions That Prioritize Sleep Quality and Cardiovascular Risk 22/12/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA